Analyst firms · Raymond James · NVTA
Raymond James NVTA price target and rating history
Invitae Corporation (NVTA) · Health Care
Raymond James rates Invitae Corporation (NVTA) Underperform with a $15 price target, as of its latest action on May 15, 2023. It has published 4 rating actions on NVTA since November 2021, including 0 upgrades and 2 downgrades.
- Current rating
- Underperform
- Price target
- $15
- Median target, all firms
- Too few
- Actions on NVTA
- 4
Raymond James price target on NVTA
Every Raymond James rating on NVTA
- May 15, 2023
- Jul 21, 2022
- Feb 28, 2022
- Nov 9, 2021
Questions about Raymond James and NVTA
- What is Raymond James's price target for NVTA?
- Raymond James's latest stated price target for Invitae Corporation (NVTA) is $15, from its action on Feb 28, 2022.
- What is Raymond James's rating on NVTA?
- Raymond James rates NVTA Underperform, a bearish rating, as of May 15, 2023.
- When did Raymond James last change its view on NVTA?
- On May 15, 2023, Raymond James downgrades to Underperform from Mkt Perform.
More NVTA rating histories
All Raymond James ratingsNVTA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.